The company said the acquisition will broaden its ability to offer a "wide range of personalized treatments, supplements and medications and accelerate the expansion into new high-impact clinical categories including low testosterone, perimenopausal and menopausal support." The blood tests also can give the company data on hormone levels, cardiac risk, stress markers, cholesterol, liver function and other indicators important for understanding whole-person care and weight loss
A 2026 retrospective study of US patients found tirzepatide produced 11.2% weight loss at 6 months versus 8.8% for semaglutide
Ozempic lawsuit settlement amounts for gastroparesis are only speculation at this point in time
We show that activating GLP-1 receptors (GLP-1R) in the OB stimulates insulin secretion in response to oral glucose in lean and diet-induced obese male mice
Glutamate is a brain hormone that excites the brain cells and helps to improve memory and learning
4 Randomized control trials on oral glutathione supplementation have yielded mixed results